Patients with platelets <30,000 can safely stay on JAK inhibitor therapy.
True
False
Which of the following is included in the DIPSS plus scoring system?
Prior polycythemia vera
Transfusion dependence
WBC <1000/μL
What is not a possible option for a patient who has myelofibrosis and pancytopenia?
High-dose ruxolitinib
Clinical trial
Stem cell transplant
0
{"name":"Patients with platelets <30,000 can safely stay on JAK inhibitor therapy.", "url":"https://www.quiz-maker.com/QAO20SJP3","txt":"Patients with platelets <30,000 can safely stay on JAK inhibitor therapy., Which of the following is included in the DIPSS plus scoring system?, What is not a possible option for a patient who has myelofibrosis and pancytopenia?","img":"https://www.quiz-maker.com/3012/images/ogquiz.png"}